Procaps Group S A's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Procaps Group S A (PROCF) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Procaps Group S A vs Its Competitors
- TTM: Trailing 12-month revenue of 374M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+353.5% annualized vs trailing 12 months).
- Peer revenue share: Procaps Group S A accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
PROCF Sales vs. its Competitors, Q4 2023
Procaps Group S A generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Major Pharmaceutical Preparations industry grew revenue 7.2% year over year, combined, vs 3.4% for Procaps Group S A. Procaps Group S A's share of combined industry revenue moved from 0.06% to 0.06%, a gain of 0.00 percentage points.